AbbVie Inc. is 183.8x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($397.44 B vs $2.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PAHC | ABBV |
|---|---|---|
| Market cap | $2.16 B | $397.44 B |
| US-listed rank | #2045 | #28 |
| Revenue (latest FY) | $1.30B | $61.16B |
| Net income (latest FY) | $48.26M | $4.23B |
| Net margin | 3.7% | 6.9% |
| P/E (trailing FY) | 44.8 | 94.0 |
| SEC filings | 733 | 1,008 |
AbbVie Inc. is 183.8x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($397.44 B vs $2.16 B).
In their latest fiscal years, PHIBRO ANIMAL HEALTH CORP reported $1.30B in revenue while AbbVie Inc. reported $61.16B.
Full pages: PHIBRO ANIMAL HEALTH CORP and AbbVie Inc., or browse the full rankings.